“Development Of A Box–Behnken Design Optimized Linagliptin Liposphere Formulation For Improved Bioavailability And Sustained Release”. Journal of Carcinogenesis, vol. 24, no. 7s, Sept. 2025, pp. 866-77, https://doi.org/10.64149/J.Carcinog.24.7s.866-877.